Delirium, Dementia, Amnestic, Cognitive Disorders  >>  AZD3839  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD3839 / AstraZeneca
NCT01348737: Assessment of Safety, Tolerability and Blood Concentrations of Single Doses of AZD3839 in Healthy Volunteers

Completed
1
72
Europe
AZD3839, AZD3839 Placebo
AstraZeneca
Alzheimer's Disease, Safety, Tolerability, Blood Concentration, Healthy Volunteers
11/11
11/11

Download Options